Bromodomain-containi... proteins in prostate cancer

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Bromodomain-containi... proteins in prostate cancer

posted on Feb 05, 2019 10:37AM

Bromodomain-containing proteins in prostate cancer

https://www.ncbi.nlm.nih.gov/pubmed/28624514

A nice review. Includes ZEN-3694 in compound table, but does not further discuss ZEN-3694. Also, I notice that this review omits mention of Gilead's GS-5829 mCRPC clinical trial, a Phase 1/2 trial which is listed as active, but not recruiting. It also omits mention of Abbvie's ABBV-744 mCRPC Phase 1 clinical trial.